ARVN
ARVINAS, INC.
ARVINAS, INC. (ARVN) has 17 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 26, 2026.
Insiders have net sold $321K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Randy Teel
- Employees:430
- HQ:New Haven, CT, US
- IPO:2018-09-27
Insider Buying
$268K
reported purchases (SEC code P)
Insider Selling
$590K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$518.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 5,696 | $46K | Jun 24 | SEC ↗ | |
| Chief Scientific Officer | Sale | 2,576 | $20K | Jun 18 | SEC ↗ | |
| President and CEO | Sale | 2,209 | $20K | May 22 | SEC ↗ | |
Teel RandyFirst filing | President and CEO | Sale | 9,657 | $96K | May 13 | SEC ↗ |
Cacace Angela MFirst filing | Chief Scientific Officer | Sale | 9,657 | $96K | May 13 | SEC ↗ |
Saik AndrewFirst filing | Chief Financial Officer | Sale | 11,139 | $111K | May 13 | SEC ↗ |
Loomis David KFirst filing | VP, Chief Accounting Officer | Sale | 1,919 | $19K | May 13 | SEC ↗ |
| Chief Medical Officer | Sale | 11,108 | $110K | May 13 | SEC ↗ | |
Berkowitz NoahFirst filing | Chief Medical Officer | Sale | 6,435 | $71K | Mar 19 | SEC ↗ |
Morrison BriggsFirst filing | Director | Purchase | 20,000 | $268K | Mar 9 | SEC ↗ |
Related companies
ARVINAS, INC. is in the Healthcare sector.